Impaired myofibroblast proliferation is a central feature of pathologic post-natal alveolar simplification
eLife · 2024
DOI: 10.7554/elife.94425 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Imran S Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, UCSF, San Francisco, United States. Hauptthemen laut MEDLINE: Myofibroblasts, Cell Proliferation, Bronchopulmonary Dysplasia, Transforming Growth Factor beta. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Child Health and Human Development, NICHD NIH HHS.
Abstract (Originalsprache)
Premature infants with bronchopulmonary dysplasia (BPD) have impaired alveolar gas exchange due to alveolar simplification and dysmorphic pulmonary vasculature. Advances in clinical care have improved survival for infants with BPD, but the overall incidence of BPD remains unchanged because we lack specific therapies to prevent this disease. Recent work has suggested a role for increased transforming growth factor-beta (TGFβ) signaling and myofibroblast populations in BPD pathogenesis, but the functional significance of each remains unclear. Here, we utilize multiple murine models of alveolar simplification and comparative single-cell RNA sequencing to identify shared mechanisms that could contribute to BPD pathogenesis. Single-cell RNA sequencing reveals a profound loss of myofibroblasts in two models of BPD and identifies gene expression signatures of increased TGFβ signaling, cell cycle arrest, and impaired proliferation in myofibroblasts. Using pharmacologic and genetic approaches, we find no evidence that increased TGFβ signaling in the lung mesenchyme contributes to alveolar simplification. In contrast, this is likely a failed compensatory response, since none of our approaches to inhibit TGFβ signaling protect mice from alveolar simplification due to hyperoxia while several make simplification worse. In contrast, we find that impaired myofibroblast proliferation is a central feature in several murine models of BPD, and we show that inhibiting myofibroblast proliferation is sufficient to cause pathologic alveolar simplification. Our results underscore the importance of impaired myofibroblast proliferation as a central feature of alveolar simplification and suggest that efforts to reverse this process could have therapeutic value in BPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, UCSF, San Francisco, United States.
- Cardiovascular Research Institute, UCSF, San Francisco, United States.
- Division of Pulmonary, Critical Care, Allergy, and Sleep, UCSF, San Francisco, United States.
- Department of Medicine, UCSF, San Francisco, United States.
ORCID-Profile: Imran S Khan, Vincent C Auyeung, Tatsuya Tsukui, Dean Sheppard
Förderung
- NHLBI NIH HHS
- National Institute of Child Health and Human Development
- NICHD NIH HHS
- University of California, San Francisco
- NIH HHS
- NCI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Khan, I. S., Molina, C., Ren, X., Auyeung, V. C., Cohen, M., Tsukui, T., Atakilit, A., & Sheppard, D. (2024). Impaired myofibroblast proliferation is a central feature of pathologic post-natal alveolar simplification. eLife. https://doi.org/10.7554/elife.94425
Vancouver
Khan IS, Molina C, Ren X, Auyeung VC, Cohen M, Tsukui T, et al. Impaired myofibroblast proliferation is a central feature of pathologic post-natal alveolar simplification. eLife. 2024. doi:10.7554/elife.94425
BibTeX
@article{Khan2024,
author = {Khan, Imran S and Molina, Christopher and Ren, Xin and Auyeung, Vincent C and Cohen, Max and Tsukui, Tatsuya and Atakilit, Amha and Sheppard, Dean},
title = {Impaired myofibroblast proliferation is a central feature of pathologic post-natal alveolar simplification},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.94425}
}
EUVIMED